Basic Research. Clinical Application. International Network.
The ISOBM is an international non-profit organization founded in 1972. It is a scientific network of researchers and clinicians dedicated to biomarkers in oncology. Main aspects are the scientific exploration and clinical implementation of new biomarkers. Special focus is on new technologies, quality issues and biomarker interpretation strategies. Experts share their experiences at annual or biannual scientific meetings.
The Journal of the ISOBM “Tumor Biology” is one of leading oncological journals.
+ + + ISOBM Board Elections for the 2026–2028 Term + + +
The ISOBM is pleased to announce that voting for the 2026 Board Elections will soon be open, from 1 April to 20 May 2026.
How to vote:
- Members can submit their votes through the official online election platform.
- Information about the candidates is available upon logging in.
Positions up for election:
- President
- Vice President
- Treasurer
- Secretary
- Board Members
- Student Member representatives
The Board will guide ISOBM’s mission of advancing research in oncology biomarkers, and strengthening international collaboration within the scientific community.
We strongly encourage all members to participate and make your voices heard.
➡️ Vote now and help shape the future of ISOBM.
Focus of ISOBM activities
- The ISOBM is one of the world’s leading societies focused on cancer biomarkers (both established and novel)
- It organizes (bi)annual conferences where the primary but not exclusive focus is on cancer biomarkers. Other topics discussed at our conferences include cancer biology, molecular therapeutics, immunotherapy and cancer screening
- The organization publishes the journal, Tumor Biology
(https://mc.manuscriptcentral.com/tumorbiology) - The organization interacts with other organization with an interest in cancer biomarkers
(e.g., The European Group on Tumor Markers or EGTM) (https://www.egtm.eu/)